Treatment with TQ (10 mg/kg/day via oral gavage) significantly downregulated the elevated Mfsn-2, TNF, and Casp3 expressions caused by CIS in rats, indicating its anti-inflammatory and anti-apoptotic effects on muscle tissue. The gene discussed is CASP3; the disease is in situ carcinoma.